Cargando…

Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia

Familial combined hyperlipidemia (FCH) is a very common inherited lipid disorder, characterized by a high risk of developing cardiovascular (CV) disease and metabolic complications, including insulin resistance (IR) and type 2 diabetes mellitus (T2DM). The prevalence of non-alcoholic fatty liver dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mandraffino, Giuseppe, Morace, Carmela, Franzè, Maria Stella, Nassisi, Veronica, Sinicropi, Davide, Cinquegrani, Maria, Saitta, Carlo, Scoglio, Riccardo, Marino, Sebastiano, Belvedere, Alessandra, Cairo, Valentina, Lo Gullo, Alberto, Scuruchi, Michele, Raimondo, Giovanni, Squadrito, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332610/ https://www.ncbi.nlm.nih.gov/pubmed/35892670 http://dx.doi.org/10.3390/biomedicines10081770

Ejemplares similares

PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy
por: Toscano, Arianna, et al.
Publicado: (2022)

Expression and Change of miRs 145, 221 and 222 in Hypertensive Subjects Treated with Enalapril, Losartan or Olmesartan
por: Mandraffino, Giuseppe, et al.
Publicado: (2021)

Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units
por: Scicali, Roberto, et al.
Publicado: (2022)

Endocan and Circulating Progenitor Cells in Women with Systemic Sclerosis: Association with Inflammation and Pulmonary Hypertension
por: Lo Gullo, Alberto, et al.
Publicado: (2021)

Abnormal left ventricular global strain during exercise-test in young healthy smokers
por: Mandraffino, Giuseppe, et al.
Publicado: (2020)

Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs?
por: Bellone, Federica, et al.
Publicado: (2023)

Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects
por: Mandraffino, Giuseppe, et al.
Publicado: (2017)

Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review
por: Lo Gullo, Alberto, et al.
Publicado: (2022)

Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients
por: Morace, Carmela, et al.
Publicado: (2023)

Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases
por: Franzè, Maria Stella, et al.
Publicado: (2022)

Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease
por: Aragona, Caterina Oriana, et al.
Publicado: (2016)

Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice
por: Rottura, Michelangelo, et al.
Publicado: (2021)

Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number
por: Lo Gullo, Alberto, et al.
Publicado: (2015)

Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis
por: Cacciola, Irene, et al.
Publicado: (2021)

Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography
por: Filomia, Roberto, et al.
Publicado: (2016)

Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma
por: Maimone, Sergio, et al.
Publicado: (2015)

Editorial: Chronic rheumatic inflammatory conditions and cardiovascular health
por: Lo Gullo, Alberto, et al.
Publicado: (2022)

Pharmacological Treatment of Diabetic and Non-Diabetic Patients With Coronary Artery Disease in the Real World of General Practice
por: Rottura, Michelangelo, et al.
Publicado: (2022)

Prevalence of Pulmonary Hypertension in an Unselected Community-Based Population: A Retrospective Echocardiographic Study—RES-PH Study
por: Imbalzano, Egidio, et al.
Publicado: (2021)

Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health
por: Bellone, Federica, et al.
Publicado: (2022)

Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions
por: Barbieri, Maria Antonietta, et al.
Publicado: (2020)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

The clinical significance of occult HBV infection
por: Squadrito, Giovanni, et al.
Publicado: (2014)

Several circulating miRNAs related to hyperlipidemia and atherosclerotic cardiovascular diseases
por: Xu, Jiang, et al.
Publicado: (2019)

High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease
por: Asero, Clelia, et al.
Publicado: (2023)

Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance
por: Franzè, Maria Stella, et al.
Publicado: (2022)

Lipofundin-Induced Hyperlipidemia Promotes Oxidative Stress and Atherosclerotic Lesions in New Zealand White Rabbits
por: Delgado Roche, Livan, et al.
Publicado: (2012)

Effect of hyperlipidemia on the expression of circadian genes in apolipoprotein E knock-out atherosclerotic mice
por: Hou, Likun, et al.
Publicado: (2009)

Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy
por: Lombardo, Daniele, et al.
Publicado: (2020)

Dietary Cholesterol Is Highly Associated with Severity of Hyperlipidemia and Atherosclerotic Lesions in Heterozygous LDLR-Deficient Hamsters
por: Wang, Jinjie, et al.
Publicado: (2019)

Biglycan Involvement in Heart Fibrosis: Modulation of Adenosine 2A Receptor Improves Damage in Immortalized Cardiac Fibroblasts
por: Scuruchi, Michele, et al.
Publicado: (2023)

Endocan Promotes Pro-Tumorigenic Signaling in Lung Cancer Cells: Modulation of Cell Proliferation, Migration and lncRNAs H19 and HULC Expression
por: Aliquò, Federica, et al.
Publicado: (2023)

Hyperlipidemia and Atherosclerotic Lesion Development in Ldlr-Deficient Mice on a Long-Term High-Fat Diet
por: Ma, Yanling, et al.
Publicado: (2012)

A Non-Linear Role of Hyperlipidemia on Progression of Intracranial Atherosclerotic Plaques and Acute Downstream Ischemic Events
por: Ke, Jianxia, et al.
Publicado: (2023)

Plasma Concentrations of Cytokines in Patients with Combined Hyperlipidemia and Atherosclerotic Plaque before Treatment Initiation—A Pilot Study
por: Basiak, Marcin, et al.
Publicado: (2022)

Endocan Knockdown Down-Regulates the Expression of Angiogenesis-Associated Genes in Il-1ß Activated Chondrocytes
por: Scuruchi, Michele, et al.
Publicado: (2023)

Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment
por: Borgia, Francesco, et al.
Publicado: (2017)

Occult Hepatitis B Virus Infection: An Update
por: Saitta, Carlo, et al.
Publicado: (2022)

Inflammasome-Driven Interleukin-1α and Interleukin-1β Production in Atherosclerotic Plaques Relates to Hyperlipidemia and Plaque Complexity
por: Jiang, Xintong, et al.
Publicado: (2019)

Impact of PCSK9 Inhibition on Proinflammatory Cytokines and Matrix Metalloproteinases Release in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Basiak, Marcin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ac79orqmfr0app6721lb6rio0k